Resident at University Clinic for Internal Medicine III, Cardiology & Angiology, Innsbruck, Austria
Innsbruck
Joined May 2010
- Tweets136
- Following128
- Followers91
- Likes320
Ivan Lechner retweeted
Check out our recently published study about the relationship between PCSK9 and reperfusion injury in revascularized #STEMI.
#whyCMR @CircImaging @ReinstadlerSJ @HolzknechtM @lechner_i @imed_tweets
More info’s: lnkd.in/eQhEWxJG
Ivan Lechner retweeted
Our latest editorial is now available
Temporal trends in #ACS outcomes: Balancing technological advances with patient complexity
sciencedirect.com/science/ar…
@lechner_i @imed_tweets @IJCardio
Ivan Lechner retweeted
#Westerndiets and #chronicdiseases.
Timon Adolph and Herbert Tilg review how Western diets contribute to the rising incidence of chronic #NCDs via key mechanisms including gut microbial rarefication and chronic #inflammation.
nature.com/articles/s41591-0…
@imed_tweets
Ivan Lechner retweeted
🫀 Nach einem ST-Hebungsinfarkt (#STEMI) werden bisher Mikrovaskuläre Gefäßverschlüsse (MVO) als Marker zur Risikoberechnung herangezogen. Eine neue #MRT-Studie unter Leitung von 🇦🇹 @imed_tweets deutet nun auf eine bessere Alternative hin. #Herzinfarkt dlvr.it/T84fwv
Ivan Lechner retweeted
Neue Studie identifiziert im #MRT sichtbare Einblutungen in den #Herzmuskel (IMH) als neuen, unabhängigen #Biomarker zur Risikoberechnung und für die Entwicklung zukünftiger Therapien nach einem #Herzinfarkt (STEMI). @imed_tweets
nachrichten.idw-online.de/20…
Ivan Lechner retweeted
Our #whyCMR paper in @JACCJournals shows that reperfused STEMI with intramyocardial hemorrhage (IMH) have a much higher risk of MACE than STEMI with MVO but not IMH. IMH=key culprit driving MACE post-MI. @lechner_i @imed_tweets jacc.org/doi/10.1016/j.jacc.…
Ivan Lechner retweeted
Top five 2024 clichés in cardiology (updated, and counting):
- “Difficult to cover this topic in x minutes” (x can be 5, 10, 20 minutes or three days, they will say it anyway)
- “Great talk, congratulations for staying on time” (which, I mean, should be normal)
- "Did you have a direct flight?" (The go-to icebreaker)
- “Packed room” (Was the room too small, or should there simply have been more chairs?)
- “Humbled”, “honored”, “flattened”, "privileged" (False modesty at its finest)
Ivan Lechner retweeted
Our most recent publication on the relation of plasma neuropeptide-Y with infarct severity after #STEMI
Check out here: sciencedirect.com/science/ar…
@CT_Tiller @HolzknechtM
@imed_tweets @lechner_i #whyCMR
Ivan Lechner retweeted
🧲💟New @journalofCMR study by @lechner_i, @ReinstadlerSJ and co-authors reveals ongoing dysglycemia linked to persistent infarct core iron in STEMI patients post-PCI, highlighting HbA1c's predictive value. Pdf via this link 👉 journalofcmr.com/article/S10… brief explanation 👇
Ivan Lechner retweeted
Culprit lesion vessel size is not a factor in myocardial tissue reperfusion failure in #STEMI: findings from a cardiac magnetic resonance imaging study. #AHAJournals @lechner_i @ReinstadlerSJ @imed_tweets ahajrnls.org/49s0IgW
Comprehensive characterization of myocardial tissue by cardiac magnetic resonance imaging reveals no association between culprit lesion vessel size and reperfusion injury in #STEMI. Read more in our latest article published in #JAHA #whyCMR @ReinstadlerSJ @imed_tweets
Ivan Lechner retweeted
Dysglycaemia and Persistent Infarct Core Iron in #STEMI sciencedirect.com/science/ar… @imed_tweets @lechner_i #whyCMR
Ivan Lechner retweeted
This week on Circulation on the run we discussed, together with @VDelgadoGarcia, our trial "CMR vs CT to Guide TAVR-CMR: A Randomized, Open-Label, Non-Inferiority Trial." Check out:
Circulation October 17, 2023 Issue circulation.libsyn.com/circu…
Ivan Lechner retweeted
All credit to the patients and staff who supported our @TheBHF #CorCTA study ahajournals.org/doi/10.1161/…
Ivan Lechner retweeted
Innovations-Boost für die Wissenschaft! Gestern präsentierten wir mit BM Martin Polaschek drei neue klinische Forschungsgruppen 🙌!
#LBG #research #science #pressekonferenz
Ivan Lechner retweeted
Cardiac MR Noninferior to CT for TAVI Planning, Small RCT Shows dlvr.it/Sw8Lkx
Ivan Lechner retweeted
Infarct severity and outcomes in #STEMI without standard modifiable risk factors (#SMuRFless) – A multicenter #whyCMR study! @imed_tweets
@lechner_i @HolzknechtM @CT_Tiller @ColinBerryMD @RNijveldt @thiele_holger @IngoEitel @feistritzerH_J @EACVIPresident
sciencedirect.com/science/ar…
Ivan Lechner retweeted
What a great discussion about special situations in cardiac pacing at the Clinical Cases Corner! #ESC2023
#cardiacpacing #deviceextraction #goleadless – at Amsterdam, The Netherlands
Ivan Lechner retweeted
It is a great pleasure to post our simultaneous publication at #ESCCongress: The randomized TAVR CMR trial now online at @CircAHA demonstartes the NI of #whyCMR TAVR guidance vs. CT guidance. @imed_tweets @lechner_i @HolzknechtM @CT_Tiller see at: ahajournals.org/doi/10.1161/…
Ivan Lechner retweeted
#TAVR-CMR trial presented by Martin Reindl in late-breaking science on imaging
#ESCCongress2023 #whyCMR
Check it out: ahajournals.org/doi/10.1161/…
@ReinstadlerSJ @lechner_i @HolzknechtM @CoTAustria @imed_tweets
